Cumberland Pharmaceuticals Revenue 2009-2019 | CPIX

Cumberland Pharmaceuticals revenue from 2009 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Cumberland Pharmaceuticals Annual Revenue
(Millions of US $)
2019 $48
2018 $41
2017 $41
2016 $33
2015 $34
2014 $37
2013 $32
2012 $49
2011 $51
2010 $46
2009 $44
2008 $35
Cumberland Pharmaceuticals Quarterly Revenue
(Millions of US $)
2019-12-31 $14
2019-09-30 $10
2019-06-30 $12
2019-03-31 $12
2018-12-31 $13
2018-09-30 $8
2018-06-30 $10
2018-03-31 $9
2017-12-31 $12
2017-09-30 $11
2017-06-30 $9
2017-03-31 $10
2016-12-31 $9
2016-09-30 $9
2016-06-30 $7
2016-03-31 $8
2015-12-31 $8
2015-09-30 $8
2015-06-30 $9
2015-03-31 $9
2014-12-31 $9
2014-09-30 $10
2014-06-30 $10
2014-03-31 $8
2013-12-31 $8
2013-09-30 $7
2013-06-30 $7
2013-03-31 $10
2012-12-31 $14
2012-09-30 $13
2012-06-30 $12
2012-03-31 $10
2011-12-31 $13
2011-09-30 $13
2011-06-30 $14
2011-03-31 $11
2010-12-31 $13
2010-09-30 $12
2010-06-30 $11
2010-03-31 $10
2009-12-31 $11
2009-09-30 $14
2009-06-30 $10
2009-03-31 $9
2008-12-31
2008-09-30 $9
2008-06-30 $8
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.054B $0.048B
Cumberland Pharmaceuticals, Inc., headquartered in Nashville, Tennessee, is a specialty pharmaceutical company focused on acquiring, developing, and commercializing branded prescription products for the acute care and gastroenterology markets. The company's lead product candidate, Amelior, which is in phase III clinical trials, is an intravenous formulation of ibuprofen for the treatment of both pain and fever. Its products also comprise Acetadote, an intravenous formulation of N-acetylcysteine for the treatment of acetaminophen poisoning; and Kristalose, a prescription laxative product, which is a crystalline form of lactulose to enhance patient acceptance and compliance. In addition, the company is developing a treatment for fluid buildup in the lungs of cancer patients and an anti-infective for treating fungal infections in immuno-compromised patients.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $53.155B 30.75
Takeda Pharmaceutical (TAK) Japan $46.598B 8.17
Astellas Pharma (ALPMY) Japan $27.590B 13.78
Eisai (ESALY) Japan $19.811B 36.91
UCB SA (UCBJF) Belgium $16.930B 0.00
Merck (MKGAF) Germany $13.479B 17.68
Grifols, S.A (GRFS) Spain $13.359B 16.61
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.874B 0.00
Neurocrine Biosciences (NBIX) United States $7.853B 218.18
Catalent (CTLT) United States $7.031B 28.93
Ionis Pharmaceuticals (IONS) United States $6.522B 19.77
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.721B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $5.371B 6.55
Orion OYJ (ORINY) Finland $5.269B 23.61
STADA ARZNEIMI (STDAF) Germany $4.685B 0.00
Forty Seven (FTSV) United States $4.596B 0.00
IPSEN SA ADR (IPSEY) France $4.543B 0.00
United Therapeutics (UTHR) United States $4.121B 0.00
Evotec AG (EVTCY) Germany $3.422B 55.18
Nektar Therapeutics (NKTR) United States $3.121B 0.00
Hypermarcas (HYPMY) Brazil $3.067B 9.33
FibroGen (FGEN) United States $2.886B 0.00
PTC Therapeutics (PTCT) United States $2.794B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.696B 50.04
ChemoCentryx (CCXI) United States $2.378B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.359B 9.54
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.586B 0.00
Xencor (XNCR) United States $1.581B 64.56
Ironwood Pharmaceuticals (IRWD) United States $1.561B 18.98
Sage Therapeutics (SAGE) United States $1.389B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.354B 37.03
Theravance Biopharma (TBPH) Cayman Islands $1.350B 0.00
Corcept Therapeutics (CORT) United States $1.340B 14.99
USANA Health Sciences (USNA) United States $1.191B 12.51
Karyopharm Therapeutics (KPTI) United States $1.184B 0.00
Zogenix (ZGNX) United States $1.048B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.003B 31.07
Heron Therapeutics (HRTX) United States $0.984B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.907B 12.63
Akebia Therapeutics (AKBA) United States $0.866B 0.00
Esperion Therapeutics (ESPR) United States $0.826B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.781B 0.00
Endo (ENDP) Ireland $0.696B 1.28
Aerie Pharmaceuticals (AERI) United States $0.617B 0.00
Tilray (TLRY) Canada $0.614B 0.00
ImmunoGen (IMGN) United States $0.579B 0.00
Molecular Templates (MTEM) United States $0.575B 0.00
Radius Health (RDUS) United States $0.548B 0.00
Collegium Pharmaceutical (COLL) United States $0.531B 0.00
Portola Pharmaceuticals (PTLA) United States $0.506B 0.00
Translate Bio (TBIO) United States $0.500B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.392B 16.10
Indivior (INVVY) United States $0.388B 2.30
Innate Pharma SA (IPHYF) France $0.385B 0.00
Siga Technologies (SIGA) United States $0.370B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.360B 12.00
Ardelyx (ARDX) United States $0.354B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.347B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.331B 0.00
DURECT (DRRX) United States $0.302B 0.00
Organogenesis Holdings (ORGO) United States $0.301B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.292B 0.00
Trillium Therapeutics (TRIL) Canada $0.290B 0.00
Harpoon Therapeutics (HARP) United States $0.281B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.275B 0.00
TherapeuticsMD (TXMD) United States $0.271B 0.00
Flexion Therapeutics (FLXN) United States $0.270B 0.00
Calithera Biosciences (CALA) United States $0.266B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.263B 0.00
Lannett Co Inc (LCI) United States $0.259B 4.18
Ocular Therapeutix (OCUL) United States $0.246B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.242B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.238B 0.00
Concert Pharmaceuticals (CNCE) United States $0.232B 0.00
OptiNose (OPTN) United States $0.201B 0.00
CASI Pharmaceuticals (CASI) United States $0.185B 0.00
Rafael Holdings (RFL) United States $0.175B 0.00
Recro Pharma (REPH) United States $0.165B 0.00
MEI Pharma (MEIP) United States $0.155B 0.00
PROFOUND MEDICL (PROF) Canada $0.151B 0.00
Jounce Therapeutics (JNCE) United States $0.142B 2.56
Nature's Sunshine Products (NATR) United States $0.141B 17.68
La Jolla Pharmaceutical (LJPC) United States $0.131B 0.00
Taiwan Liposome (TLC) Taiwan $0.126B 0.00
VAXART, INC (VXRT) United States $0.122B 0.00
KalVista Pharmaceuticals (KALV) United States $0.120B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.112B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.109B 0.00
Redhill Biopharma (RDHL) Israel $0.101B 0.00
CannTrust Holdings (CTST) Canada $0.090B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.084B 0.00
Hemispherx BioPharma (AIM) United States $0.083B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.083B 0.00
IMV INC (IMV) Canada $0.082B 0.00
Champions Oncology (CSBR) United States $0.081B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.074B 0.00
SCYNEXIS (SCYX) United States $0.074B 0.00
Biomerica (BMRA) United States $0.069B 0.00
CTI BioPharma (CTIC) United States $0.069B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.068B 0.00
Xeris Pharmaceuticals (XERS) United States $0.066B 0.00
Aquestive Therapeutics (AQST) United States $0.065B 0.00
Otonomy (OTIC) United States $0.058B 0.00
CV Sciences (CVSI) United States $0.056B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.055B 0.00
Nivalis Therapeutics (ALPN) United States $0.054B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.052B 0.00
Onconova Therapeutics (ONTX) United States $0.049B 0.00
Sundial Growers (SNDL) Canada $0.048B 0.00
Infinity Pharmaceuticals (INFI) United States $0.047B 0.00
PharmAthene (ALT) United States $0.047B 0.00
GTx (ONCT) United States $0.046B 0.00
Aclaris Therapeutics (ACRS) United States $0.043B 0.00
Natural Alternatives (NAII) United States $0.043B 19.63
MediWound (MDWD) Israel $0.041B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.039B 130.71
Forward Pharma (FWP) Denmark $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
PolarityTE (PTE) United States $0.036B 0.00
IsoRay (ISR) United States $0.036B 0.00
Neos Therapeutics (NEOS) United States $0.036B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.033B 0.00
Heat Biologics (HTBX) United States $0.030B 0.00
AgeX Therapeutics (AGE) United States $0.030B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.026B 0.00
Jaguar Animal Health (JAGX) United States $0.025B 0.00
Mannatechorporated (MTEX) United States $0.025B 7.79
Eyegate Pharmaceuticals (EYEG) United States $0.025B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.024B 0.00
ElectroCore (ECOR) United States $0.023B 0.00
Novan (NOVN) United States $0.022B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.022B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.021B 0.00
Cardiome Pharma (CORV) Canada $0.021B 0.00
Lipocine (LPCN) United States $0.021B 0.00
India Globalization Capital (IGC) United States $0.018B 0.00
Bio-Path Holdings (BPTH) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.013B 0.00
China SXT Pharmaceuticals (SXTC) China $0.013B 0.00
Cyanotech (CYAN) United States $0.012B 0.00
Shineco (TYHT) China $0.012B 0.00
Can-Fite Biopharma (CANF) Israel $0.011B 0.00
KemPharm (KMPH) United States $0.011B 0.00
Vical (BBI) United States $0.010B 0.00
Regulus Therapeutics (RGLS) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Midatech Pharma (MTP) United Kingdom $0.007B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.006B 0.00
HANCOCK JAFFE (HJLI) United States $0.005B 0.00
Flex Pharma (SLRX) United States $0.003B 0.00
Xenetic Biosciences (XBIO) United States $0.003B 0.00
RXi Pharmaceuticals (PHIO) United States $0.001B 0.00